Segment from Joe Rogan Experience podcast exposes how Big Pharma ignores cheap, effective treatments

A clip from Joe Rogan’s November 2023 interview with Dr. William Makis is going viral online as many people discuss the controversial anti-parasite drug fenbendazole as a potential cancer treatment.

Showing an article from Vigilant Fox onscreen during the interview, Rogan explained the dewormer is being labeled a “miracle drug” that has “at least 12 prevent anti-cancer mechanisms in vitro and in vivo.”

The Overlooked Miracle Drug for Cancer? Why Big Pharma Fears Fenbendazole

“Fenbendazole has at least 12 proven anti-cancer mechanisms in vitro and in vivo,” wrote cancer researcher Dr. William Makis

“So why are there no Fenbendazole clinical trials for cancer? The answer seems… pic.twitter.com/qieH8AvSnQ

— The Vigilant Fox 🦊 (@VigilantFox) May 8, 2024

In the article, cancer researcher Dr. William Makis MD provides extensive research and asks why fenbendazole is not approved by the FDA for human consumption despite all indications it’s safe.

Dr. Makis wrote, “The answer seems rather obvious: it’s very cheap, it’s safe, and it seems to be very effective. Fenbendazole is not going to make anyone rich, and in cancer treatments, that is a non-starter.”

Dr. Pierre Kory commented on the JRE clip, writing, “Same story over and over – safe, inexpensive medicines repurposed to treat other diseases get ignored (and/or attacked). Fixed feature of our medical system as I describe in detail in my book.”

Same story over and over – safe, inexpensive medicines repurposed to treat other diseases get ignored (and/or attacked). Fixed feature of our medical system as I describe in detail in my book: https://t.co/ybC20OOpKG https://t.co/cAFCx6kQOl

— Pierre Kory, MD MPA (@PierreKory) May 9, 2024

See the original article discussed on the JRE podcasts below as well as a related link:

Related:

Fighting Cancer With Fenbendazole: Big Pharma’s Worst Nightmarehttps://t.co/kVkc7qxxqc

— The Vigilant Fox 🦊 (@VigilantFox) May 8, 2024

By

Leave a Reply